Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 4, 2010, Pages

  Baraboi, Elena Dana ^a   Smith, Pauline ^b   Ferguson, Alastair V ^b   Richard, Denis ^a  

^a LAVAL UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EXENDIN 4; GLUCAGON DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; MESSENGER RNA; PROTEIN C FOS; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ANTERIOR HYPOTHALAMUS; ARCUATE NUCLEUS; AREA POSTREMA; ARTICLE; BODY WEIGHT; BRAIN; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; ELECTROLYSIS; FOOD INTAKE; GENE EXPRESSION; GLUCOSE METABOLISM; HYPOPHAGIA; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC CORTEX; MALE; NONHUMAN; PARABRACHIAL NUCLEUS; PRIORITY JOURNAL; RAT; RHOMBENCEPHALON; SOLITARY TRACT NUCLEUS; STRIA TERMINALIS; SUBFORNICAL ORGAN; SUPRAOPTIC NUCLEUS; THALAMUS VENTRAL NUCLEUS;

ANIMALS; AREA POSTREMA; BODY COMPOSITION; BODY WEIGHT; BRAIN; DEGLUTITION DISORDERS; ENERGY INTAKE; ENERGY METABOLISM; GENES, FOS; GLUCOKINASE; HYPOGLYCEMIC AGENTS; MALE; ORGAN SIZE; PEPTIDES; RATS; RATS, WISTAR; RNA, HETEROGENEOUS NUCLEAR; RNA, MESSENGER; SUBFORNICAL ORGAN; VENOMS;

EID: 77949837737     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00326.2009     Document Type: Article

References (67)

1. Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, Ghatei MA, Bloom SR. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044: 127-131, 2005.
2. Al-Barazanji KA, Arch JR, Buckingham RE, Tadayyon M. Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats. Obes Res 8: 317-323, 2000.
3. Aziz A, Anderson GH, Giacca A, Cho F. Hyperglycemia after protein ingestion concurrent with injection of a GLP-1 receptor agonist in rats: a possible role for dietary peptides. Am J Physiol Regul Integr Comp Physiol 289: R688-R694, 2005.
4. Baggio LL, Huang Q, Brown TJ, Drucker DJ. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127: 546-558, 2004.
5. Baggio LL, Huang Q, Brown TJ, Drucker DJ. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes 53: 2492-2500, 2004.
6. Baggio LL, Huang Q, Cao X, Drucker DJ. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis. Gastroenterology 134: 1137-1147, 2008.
7. Barrera JG, D'Alessio DA, Drucker DJ, Woods SC, Seeley RJ. Differences in the central anorectic effects of GLP-1 and exendin-4 in rats. Diabetes 58: 2820-2827, 2009.
8. Beck B. Neuropeptide Y in normal eating and in genetic and dietaryinduced obesity. Philos Trans R Soc Lond B Biol Sci 361: 1159-1185, 2006.
9. Berthoud HR. Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev 26: 393-428, 2002.
10. Carlson SH, Collister JP, Osborn JW. The area postrema modulates hypothalamic Fos responses to intragastric hypertonic saline in conscious rats. Am J Physiol Regul Integr Comp Physiol 275: R1921-R1927, 1998.
11. Chronwall BM. Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 6 Suppl 2: 1-11, 1985.
12. Cobos A, Lima D, Almeida A, Tavares I. Brain afferents to the lateral caudal ventrolateral medulla: a retrograde and anterograde tracing study in the rat. Neuroscience 120: 485-498, 2003.
13. Curtis KS, Sved AF, Verbalis JG, Stricker EM. Lithium chlorideinduced anorexia, but not conditioned taste aversions, in rats with area postrema lesions. Brain Res 663: 30-37, 1994.
14. Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes 44: 1126-1131, 1995.
15. Drucker DJ. Biologic actions and therapeutic potential of the proglucagon-derived peptides. Nat Clin Pract Endocrinol Metab 1: 22-31, 2005.
16. Edwards GL, Ritter RC. Ablation of the area postrema causes exaggerated consumption of preferred foods in the rat. Brain Res 216: 265-276, 1981.
17. Edwards GL, Ritter RC. Lateral parabrachial lesions attenuate ingestive effects of area postrema lesions. Am J Physiol Regul Integr Comp Physiol 256: R306-R312, 1989.
18. Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267: 7402-7405, 1992.
19. Even PC, Mokhtarian A, Pele A. Practical aspects of indirect calorimetry in laboratory animals. Neurosci Biobehav Rev 18: 435-447, 1994.
20. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101: 515-520, 1998.
21. Flint A, Raben A, Rehfeld JF, Holst JJ, Astrup A. The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans. Int J Obes Relat Metab Disord 24: 288-298, 2000.
22. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B. Exendin-4 is a high potency agonist and truncated exendin-(9 -39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem 268: 19650-19655, 1993.
23. Goke R, Larsen PJ, Mikkelsen JD, Sheikh SP. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7: 2294-2300, 1995.
24. Herbert H, Moga MM, Saper CB. Connections of the parabrachial nucleus with the nucleus of the solitary tract and the medullary reticular formation in the rat. J Comp Neurol 293: 540-580, 1990.
25. Herman JP, Schafer MK, Thompson RC, Watson SJ. Rapid regulation of corticotropin-releasing hormone gene transcription in vivo. Mol Endocrinol 6: 1061-1069, 1992.
26. Hoffman GE, Smith MS, Verbalis JG. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol 14: 173-213, 1993.
27. Hyde TM, Miselis RR. Effects of area postrema/caudal medial nucleus of solitary tract lesions on food intake and body weight. Am J Physiol Regul Integr Comp Physiol 244: R577-R587, 1983.
28. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev 20: 876-913, 1999.
29. Kieffer TJ, McIntosh CH, Pederson RA. Degradation of glucosedependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136: 3585-3596, 1995.
30. Kott JN, Ganfield CL, Kenney NJ. Area postrema/nucleus of the solitary tract ablations: analysis of the effects of hypophagia. Physiol Behav 32: 429-435, 1984.
31. Lacroix S, Vallieres L, Rivest S. c-fos mRNA pattern and corticotropinreleasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type. J Neuroimmunol 70: 163-179, 1996.
32. Larsen PJ, Fledelius C, Knudsen LB, Tang-Christensen M. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 50: 2530-2539, 2001.
33. Larsen PJ, Tang-Christensen M, Jessop DS. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 138: 4445-4455, 1997.
34. Malendowicz LK, Nussdorfer GG, Nowak KW, Ziolkowska A, Tortorella C, Trejter M. Exendin-4, a GLP-1 receptor agonist, stimulates pituitary-adrenocortical axis in the rat: investigations into the mechanism(s) underlying Ex4 effect. Int J Mol Med 12: 237-241, 2003.
35. McCaughey SA, Fitts DA, Tordoff MG. Lesions of the subfornical organ decrease the calcium appetite of calcium-deprived rats. Physiol Behav 79: 605-612, 2003.
36. Merchenthaler I, Lane M, Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 403: 261-280, 1999.
37. Miselis RR. The efferent projections of the subfornical organ of the rat: a circumventricular organ within a neural network subserving water balance. Brain Res 230: 1-23, 1981.
38. Moga MM, Saper CB, Gray TS. Bed nucleus of the stria terminalis: cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat. J Comp Neurol 283: 315-332, 1989.
39. Muglia LJ, Bethin KE, Jacobson L, Vogt SK, Majzoub JA. Pituitaryadrenal axis regulation in CRH-deficient mice. Endocr Res 26: 1057-1066, 2000.
40. Nadreau E, Baraboi ED, Samson P, Blouin A, Hould FS, Marceau P, Biron S, Richard D. Effects of the biliopancreatic diversion on energy balance in the rat. Int J Obes (Lond) 30: 419-429, 2006.
41. Nakagawa A, Satake H, Nakabayashi H, Nishizawa M, Furuya K, Nakano S, Kigoshi T, Nakayama K, Uchida K. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci 110: 36-43, 2004.
42. Navarro M, Rodriquez de Fonseca F, Alvarez E, Chowen JA, Zueco JA, Gomez R, Eng J, Blazquez E. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J Neurochem 67: 1982-1991, 1996.
43. Orskov C, Poulsen SS, Moller M, Holst JJ. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes 45: 832-835, 1996.
44. Peters CT, Choi YH, Brubaker PL, Anderson GH. A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats. J Nutr 131: 2164-2170, 2001.
45. Ritter RC, Edwards GL. Area postrema lesions cause overconsumption of palatable foods but not calories. Physiol Behav 32: 923-927, 1984.
46. Rivest S, Laflamme N, Nappi RE. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci 15: 2680-2695, 1995.
47. Rodriquez de Fonseca F, Navarro M, Alvarez E, Roncero I, Chowen JA, Maestre O, Gomez R, Munoz RM, Eng J, Blazquez E. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism 49: 709-717, 2000.
48. Sagar SM, Sharp FR, Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240: 1328-1331, 1988.
49. Sandoval DA, Bagnol D, Woods SC, D'Alessio DA, Seeley RJ. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 57: 2046-2054, 2008.
50. Schirra J, Kuwert P, Wank U, Leicht P, Arnold R, Goke B, Katschinski M. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Proc Assoc Am Physicians 109: 84-97, 1997.
51. Seo S, Ju S, Chung H, Lee D, Park S. Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats. Endocr J 55: 867-874, 2008.
52. Shapiro RE, Miselis RR. The central neural connections of the area postrema of the rat. J Comp Neurol 234: 344-364, 1985.
53. Simmons DM, Arriza JL, Swanson LW. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes. J Histotechnol 12: 169-181, 1989.
54. Simonson DC, DeFronzo RA. Indirect calorimetry: methodological and interpretative problems. Am J Physiol Endocrinol Metab 258: E399-E412, 1990.
55. Sunn N, McKinley MJ, Oldfield BJ. Circulating angiotensin II activates neurones in circumventricular organs of the lamina terminalis that project to the bed nucleus of the stria terminalis. J Neuroendocrinol 15: 725-731, 2003.
56. Swanson LW, Lind RW. Neural projections subserving the initiation of a specific motivated behavior in the rat: new projections from the subfornical organ. Brain Res 379: 399-403, 1986.
57. Szayna M, Doyle ME, Betkey JA, Holloway HW, Spencer RG, Greig NH, Egan JM. Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology 141: 1936-1941, 2000.
58. Takahashi Y, Smith P, Ferguson A, Pittman QJ. Circumventricular organs and fever. Am J Physiol Regul Integr Comp Physiol 273: R1690-R1695, 1997.
59. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146: 3748-3756, 2005.
60. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M, Sheikh SP. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol Regul Integr Comp Physiol 271: R848-R856, 1996.
61. Tauchi M, Zhang R, D'Alessio DA, Seeley RJ, Herman JP. Role of central glucagon-like peptide-1 in hypothalamo-pituitary-adrenocortical facilitation following chronic stress. Exp Neurol 210: 458-466, 2008.
62. Tauchi M, Zhang R, D'Alessio DA, Stern JE, Herman JP. Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei. J Chem Neuroanat 36: 144-149, 2008.
63. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72, 1996.
64. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38: 665-673, 1993.
65. Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, Elmquist JK. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci 23: 2939-2946, 2003.
66. Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, Elmquist JK. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest 110: 43-52, 2002.
67. Young AA, Gedulin BR, Bhavsar S, Bodkin N, Jodka C, Hansen B, Denaro M. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes 48: 1026-1034, 1999.